NASDAQ · Shell Companies
Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) Stock
$12.11
-0.08%
NASDAQ: AFJK
Financial Services
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Update: Aimei Health Technology Shares Fall After Terminating Merger Deal With United Hydrogen
MT Newswires · Jul 9, 2026
Top Midday Decliners
MT Newswires · Jul 9, 2026
Top Premarket Decliners
MT Newswires · Jul 9, 2026
Aimei Health Terminates Merger Deal With United Hydrogen Group; Shares Drop Pre-Bell
MT Newswires · Jul 9, 2026
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
GlobeNewswire · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held64.96%
Institutions Held32.03%
Institutions Float Held91.43%
Peer Comparison
About Aimei Health Technology Co., Ltd - Ordinary Share
Aimei Health Technology Co., Ltd - Ordinary Share is led by CEO Junheng Xie, employs 2 people, headquartered in US, publicly traded since 2024.
Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) stock trades at $12.11 with a market capitalization of $38.34M. The stock is valued at a price-to-earnings (P/E) ratio of 177.57, price-to-book of 1.57, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $6.75 and $130.37, and currently trades 90.7% below its 52-week high.
On profitability, Aimei Health Technology Co., Ltd - Ordinary Share generates a return on equity (ROE) of 2.49%, return on capital employed of -7.31%, an operating margin of 0.00%, a net profit margin of 0.00%.